SQZ Biotechnologies Co. (SQZ) Social Stream
SQZ BIOTECHNOLOGIES CO (SQZ) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SQZ BIOTECHNOLOGIES CO.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 5 | $46 | $29 | $35 | $0.27 | 12862.96% |
| 2021-12-16 | 4 | $46 | $29 | $33.75 | $0.27 | 12400% |
| 2022-01-03 | 4 | $52 | $29 | $35.25 | $0.27 | 12955.56% |
| 2022-02-11 | 3 | $52 | $29 | $35.25 | $0.27 | 12955.56% |
| 2022-03-17 | 3 | $42 | $18 | $28.75 | $0.27 | 10548.15% |
| 2022-05-10 | 3 | $42 | $18 | $28.25 | $0.27 | 10362.96% |
| 2022-05-18 | 4 | $42 | $16 | $27 | $0.27 | 9900% |
| 2022-05-25 | 4 | $42 | $16 | $25 | $0.27 | 9159.26% |
| 2022-08-06 | 4 | $42 | $9 | $22.2 | $0.27 | 8122.22% |
| 2022-10-03 | 4 | $42 | $9 | $21.8 | $0.27 | 7974.07% |
| 2022-10-06 | 6 | $42 | $9 | $20.666 | $0.27 | 7554.07% |
| 2022-10-21 | 6 | $42 | $9 | $19.143 | $0.27 | 6990% |
| 2022-11-11 | 6 | $42 | $9 | $19 | $0.27 | 6937.04% |
| 2022-12-01 | 6 | $42 | $2 | $17.333 | $0.27 | 6319.63% |
| 2023-01-02 | 6 | $34 | $2 | $16 | $0.27 | 5825.93% |
| 2023-03-22 | 5 | $34 | $2 | $16.4 | $0.27 | 5974.07% |
| 2023-05-10 | 5 | $34 | $2 | $13.75 | $0.27 | 4992.59% |
The Trend in the Analyst Price Target
Over the past 29 months, SQZ's average price target has gone down $24.58.
Over the past 40 weeks, SQZ's average upside potential has been 1,183.3%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-05 | 4 | 42 | 9 | 22.200 | 3.390 | 554.87% |
| 2022-10-06 | 5 | 42 | 9 | 20.666 | 2.790 | 640.72% |
| 2022-10-21 | 6 | 42 | 9 | 19.143 | 2.850 | 571.68% |
| 2022-11-11 | 6 | 42 | 9 | 19.000 | 2.740 | 593.43% |
| 2023-01-19 | 5 | 34 | 2 | 16.400 | 0.727 | 2155.85% |
SQZ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
SQZ's average broker recommendation rating worsened by 1 over the prior 26 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SQZ as an investment opportunity.
- In the context of all US stocks, SQZ BIOTECHNOLOGIES CO's upside potential (average analyst target price relative to current price) is higher than 2297.31% of them.
- SQZ has a lower variance in analysts' estimates than -1838.93% of all US stocks.
- SQZ has a greater number of analysts covering the stock than 557.48% of Healthcare stocks.
- SQZ BIOTECHNOLOGIES CO's average analyst price target is greater than 1441.29% of stocks in the small market cap category.
In the Pharmaceutical Products industry, SRZN, FDMT, and CGEM are the three stocks most similar to SQZ BIOTECHNOLOGIES CO regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is SQZ a Buy, Hold or Sell? See the POWR Ratings now!